DK0387178T4 - Fremgangsmåde til fremstilling af clavulansyre og farmaceutisk acceptable salte deraf ud fra fermerteringsmedier med Streptomyces sp. - Google Patents

Fremgangsmåde til fremstilling af clavulansyre og farmaceutisk acceptable salte deraf ud fra fermerteringsmedier med Streptomyces sp.

Info

Publication number
DK0387178T4
DK0387178T4 DK90500023T DK90500023T DK0387178T4 DK 0387178 T4 DK0387178 T4 DK 0387178T4 DK 90500023 T DK90500023 T DK 90500023T DK 90500023 T DK90500023 T DK 90500023T DK 0387178 T4 DK0387178 T4 DK 0387178T4
Authority
DK
Denmark
Prior art keywords
pharmaceutically acceptable
acceptable salts
streptomyces
preparation
clavulanic acid
Prior art date
Application number
DK90500023T
Other languages
English (en)
Other versions
DK0387178T3 (da
Inventor
Alvarez Concepcion Garcia
Urries Senante Pilar J De
Martin Pablo Floriano
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8260712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0387178(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of DK0387178T3 publication Critical patent/DK0387178T3/da
Application granted granted Critical
Publication of DK0387178T4 publication Critical patent/DK0387178T4/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90500023T 1989-03-01 1990-02-28 Fremgangsmåde til fremstilling af clavulansyre og farmaceutisk acceptable salte deraf ud fra fermerteringsmedier med Streptomyces sp. DK0387178T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES8900748A ES2010143A6 (es) 1989-03-01 1989-03-01 Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.

Publications (2)

Publication Number Publication Date
DK0387178T3 DK0387178T3 (da) 1997-06-16
DK0387178T4 true DK0387178T4 (da) 2001-07-30

Family

ID=8260712

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90500023T DK0387178T4 (da) 1989-03-01 1990-02-28 Fremgangsmåde til fremstilling af clavulansyre og farmaceutisk acceptable salte deraf ud fra fermerteringsmedier med Streptomyces sp.

Country Status (7)

Country Link
EP (1) EP0387178B9 (da)
AT (1) ATE147103T1 (da)
DE (1) DE69029527T3 (da)
DK (1) DK0387178T4 (da)
ES (1) ES2010143A6 (da)
GR (1) GR3022981T3 (da)
PT (1) PT93313B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2010143A6 (es) 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
GB9222841D0 (en) * 1992-10-31 1992-12-16 Smithkline Beecham Plc Novel process
SI9300296B (sl) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
AT475U1 (de) * 1992-06-11 1995-11-27 Smithkline Beecham Plc Verfahren zur herstellung von clavulansaeure
AT1447U1 (de) * 1992-06-11 1997-05-26 Smithkline Beecham Plc Neue salze von clavulansäure
GB2282810B (en) * 1992-06-11 1997-02-26 Smithkline Beecham Plc Preparation or purification of clavulanic acid
AT1446U1 (de) * 1992-10-31 1997-05-26 Smithkline Beecham Plc Verfahren zur herstellung und/oder reinigung von clavulansäure
GB9305565D0 (en) * 1993-03-18 1993-05-05 Smithkline Beecham Plc Novel compounds and processes
US5821364A (en) * 1993-03-26 1998-10-13 Gist-Brocades N.V. Diamine salts of clavulanic acid
US5760218A (en) * 1993-03-26 1998-06-02 Gist-Brocades N.V. Diamine salts of clavulanic acid
US5741903A (en) * 1993-03-26 1998-04-21 Gist-Brocades N.V. Diamine salts for purification of clavulanic acid
DE69400334T2 (de) * 1993-03-26 1997-02-13 Gist Brocades Nv Diaminsalze von clavulansäure
DE4318916A1 (de) * 1993-06-07 1994-12-08 Bayer Ag Cyclobutylazole
GB9401969D0 (en) * 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9426261D0 (en) * 1994-12-24 1995-02-22 Spurcourt Ltd Clavulanic acid salts
DE69618045D1 (de) * 1995-02-25 2002-01-31 Spurcourt Ltd Clavulansäure Salz
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
AT404728B (de) * 1996-11-27 1999-02-25 Biochemie Gmbh Verfahren zur herstellung von clavulansäure-aminsalzen
CN1312814A (zh) * 1998-07-16 2001-09-12 Dsm公司 制备棒酸盐类及其酯类的改进方法
CN105384758B (zh) * 2015-12-01 2018-05-01 国药集团威奇达药业有限公司 克拉维酸胺盐的制备方法
CN108546269B (zh) * 2018-05-22 2019-10-11 国药集团威奇达药业有限公司 从结晶母液中回收克拉维酸叔丁胺盐的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140764A (en) * 1974-12-18 1979-02-20 Beecham Group Limited β-Lactamase inhibitors and process for their preparation
GB1543563A (en) 1975-02-07 1979-04-04 Glaxo Lab Ltd Beta-lactam antibiotic in purified form
DE3063683D1 (en) 1979-08-24 1983-07-14 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
MX7417E (es) * 1984-10-27 1988-10-14 Antibioticos Sa Metodo para la preparacion de acido clavulanico y sus derivados
ES2010143A6 (es) 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.

Also Published As

Publication number Publication date
GR3022981T3 (en) 1997-06-30
PT93313B (pt) 1998-06-30
DE69029527T2 (de) 1997-07-24
DE69029527T3 (de) 2001-11-08
EP0387178B2 (en) 2001-04-18
PT93313A (pt) 1990-11-07
EP0387178A1 (en) 1990-09-12
ES2010143A6 (es) 1989-10-16
DE69029527D1 (de) 1997-02-13
EP0387178B9 (en) 2002-09-25
EP0387178B1 (en) 1997-01-02
ATE147103T1 (de) 1997-01-15
DK0387178T3 (da) 1997-06-16

Similar Documents

Publication Publication Date Title
DK0387178T4 (da) Fremgangsmåde til fremstilling af clavulansyre og farmaceutisk acceptable salte deraf ud fra fermerteringsmedier med Streptomyces sp.
IE780642L (en) CEPHALOSPORIN DERIVATIVES AND RELATED ß-LACTAMS.
DZ1766A1 (fr) Inhibiteurs de vih protéase utiles pour le traitement du sida.
DK0748387T3 (da) Fremgangsmåde til isolation af clavulansyre og farmaceutisk acceptable salte deraf fra fermenteringsvæsken af Streptomyces sp. P 6621 FERM P 2804
IE860598L (en) ß-Lactam antibiotics, process for their preparation and¹their use as and in medicine
IE43840L (en) Clavulanic acid derivatives
DE68906200D1 (de) Kondensierte pyrazol-3-oxo-propannitril-derivate und verfahren zu deren herstellung.
AU8088487A (en) Use of carboxylic acid amides
FI103046B1 (fi) Menetelmä lääkeaineina käyttökelpoisten pyrrolidinyylitiokarbapeneemijohdannaisten valmistamiseksi
ATE82976T1 (de) Cephalosporinderivate.
IS4066A (is) Afleiður fjölhydroxyfimmhringaefna, framleiðsla þeirra og notkun sem lyfja
EP0453574A4 (en) Cephalosporin derivative
DE3578423D1 (de) Neue cephalosporine und verfahren zu ihrer herstellung.
JPS5671092A (en) Optical active cephalosporin analogous derivative
ES2001410A6 (es) Un procedimiento para la preparacion de nuevos derivados de clavam, utiles para la preparacion de acido clavulanico, e intermedios de los mismos.
ES442217A1 (es) Procedimiento para la obtencion de derivados cefem.
ES8107238A1 (es) Proceso para la produccion de 1-oxadestiacefalosporina
JPS5394093A (en) Novel process for preparation of 7-amino-cephalosporanic acid and their derivatives
SE7707366L (sv) Forfarande for framstellning av 7alfa-metoxi-cefalosporansyraderivat
DK159320C (da) 19-epi-dianemycin og salte deraf, fremgangsmaade til fremstilling af 19-epi-dianemycin og mikroorganismekultur til anvendelse ved fremgangsmaaden samt farmaceutisk praeparat indeholdende 19-epi-dianemycin
EP0365329A3 (en) Antibiotics active against anaerobic bacteria, their production and use, and strains of enterobacter producing the same
YU12191A (sh) Kristalni hidrohlorid novog beta-laktamskog antibiotika i postupak za njegovo dobijanje
JPS53104796A (en) Preparation of antibiotics
AU571956B2 (en) 3-azinomethyl rifamycins
JPS568694A (en) Preparation of l-glutamic acid by fermentation